Indication: 

• Ongoing symptomatic treatment of asthma and other reversible obstructive pulmonary disease; - in patients requiring daily intake of short-acting, rapid-acting beta2 agonists, - and/or in case of nocturnal symptoms, in combination with continuous anti-inflammatory therapy such as inhaled corticosteroids. 
• Preventive treatment of exertion-induced asthma. 

Composition: Formoterol Fumarate 12mcg

Pack Size: 60

Form: Capsule

Manufacturer: Teriak

Manufacturing Country: Tunisia

Registration Number: 165020/1